United Arab Emirates · Bentham Science Publishers B...

workspace_premium Q4 — Drug Discovery lock Subscription

Recent Patents on CNS Drug Discovery

Recent Patents on CNS Drug Discovery is a journal indexed in SJR in Drug Discovery and Psychiatry and Mental Health with an H index of 32. It has a best quartile of Q4.

ISSN: 1574-8898

Publisher: Bentham Science Publishers B.V.

Category: Drug Discovery

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD Q4

H-index 32

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

Docs (year)

Docs 3y

Total refs

Cites 3y

Citable 3y

Cites/Doc 2y

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Current Options in the Treatment of Mitochondrial Diseases

Zolpidem Therapy for Movement Disorders

Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs

Glucocorticoids Involvement in the Control of CNS Excitability

Gap Junctions as Therapeutic Targets in Brain Injury Following Hypoxia- Ischemia

Future Targeted Disease Modifying Drugs for Alzheimer's Disease

Editorial :

Editorial

Drugs and Aggression

Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs

Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?

Dexmedetomidine: A Novel Anesthetic Agent for Middle Ear Surgery

SHOW MORE ARTICLES

Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments

A Rational Approach on the Use of Sex Steroids in Multiple Sclerosis

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease

Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis

Brain Permeable Nanoparticles

Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases

BACE Inhibitors as Potential Therapeutics for Alzheimers disease

Author Index To Volume 1

Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents

Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

An Update on Peptide Drugs for Voltage-Gated Calcium Channels

FAQs

SJR is not available (NPD) for Recent Patents on CNS Drug Discovery in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Recent Patents on CNS Drug Discovery is 35%.

Recent Patents on CNS Drug Discovery

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Recent Patents on CNS Drug Discovery?

What is the APC / publication cost?

What is the acceptance rate?